Trial intelligence / Profile preview

Rivastigmine for major depressive disorder

IRCT2017020132236N4Phase 3Completed

Sponsor

Mazandaran University of Medical Sciences

Start

Sep 2014

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1